Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression - PubMed (original) (raw)

Review

. 2004 Jun;25(6):295-305.

doi: 10.1016/j.it.2004.03.006.

Affiliations

• PMID: 15145319
• DOI: 10.1016/j.it.2004.03.006

Review

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression

Wook Lew et al. Trends Immunol. 2004 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.
  Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A, Wong WH, Bowcock AM. Zhou X, et al. Physiol Genomics. 2003 Mar 18;13(1):69-78. doi: 10.1152/physiolgenomics.00157.2002. Epub 2003 Mar 18. Physiol Genomics. 2003. PMID: 12644634
• Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
  Bedini C, Nasorri F, Girolomoni G, Pità Od, Cavani A. Bedini C, et al. Br J Dermatol. 2007 Aug;157(2):249-58. doi: 10.1111/j.1365-2133.2007.07945.x. Epub 2007 May 8. Br J Dermatol. 2007. PMID: 17489975
• IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
  Ortega C, Fernández-A S, Carrillo JM, Romero P, Molina IJ, Moreno JC, Santamaría M. Ortega C, et al. J Leukoc Biol. 2009 Aug;86(2):435-43. doi: 10.1189/JLB.0109046. J Leukoc Biol. 2009. PMID: 19487306
• Psoriasis as a T cell-mediated autoimmune disease.
  Barker JN. Barker JN. Hosp Med. 1998 Jul;59(7):530-3. Hosp Med. 1998. PMID: 9798540 Review.
• T cell priming by tissue-derived dendritic cells: new insights from recent murine studies.
  Sillé FC, Visser A, Boes M. Sillé FC, et al. Cell Immunol. 2005 Oct;237(2):77-85. doi: 10.1016/j.cellimm.2005.10.004. Epub 2005 Dec 19. Cell Immunol. 2005. PMID: 16360134 Review.

Cited by

• SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.
  Morelli M, Madonna S, Albanesi C. Morelli M, et al. Front Immunol. 2024 Jun 21;15:1393799. doi: 10.3389/fimmu.2024.1393799. eCollection 2024. Front Immunol. 2024. PMID: 38975347 Free PMC article. Review.
• Blockade of IL-18Rα-mediated signaling pathway exacerbates neutrophil infiltration in imiquimod-induced psoriasis murine model.
  Akazawa H, Nozaki Y, Yamazawa H, Ishimura K, Ashida C, Okada A, Kinoshita K, Matsumura I. Akazawa H, et al. Front Med (Lausanne). 2023 Oct 27;10:1293132. doi: 10.3389/fmed.2023.1293132. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37964882 Free PMC article.
• Inflammatory Cytokines in Psoriatic Arthritis: Understanding Pathogenesis and Implications for Treatment.
  Lee BW, Moon SJ. Lee BW, et al. Int J Mol Sci. 2023 Jul 19;24(14):11662. doi: 10.3390/ijms241411662. Int J Mol Sci. 2023. PMID: 37511421 Free PMC article. Review.
• The Therapeutic Effect of Tacrolimus in a Mouse Psoriatic Model is Associated with the Induction of Myeloid-derived Suppressor Cells.
  Chen S, Liao P, Xi L, Yang Y, Wu W, Islam MS, Lin Z, Zheng Y, Chen X. Chen S, et al. Rheumatol Immunol Res. 2022 Dec 31;3(4):190-197. doi: 10.2478/rir-2022-0034. eCollection 2022 Dec. Rheumatol Immunol Res. 2022. PMID: 36879838 Free PMC article.
• Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells.
  Li B, Su R, Yan H, Liu J, Gao C, Li X, Wang C. Li B, et al. Front Immunol. 2022 Jul 22;13:907729. doi: 10.3389/fimmu.2022.907729. eCollection 2022. Front Immunol. 2022. PMID: 35935983 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information